It is apparent that if (or more accurately when) Brilacidin
It is apparent that if (or more accurately when) Brilacidin becomes the "go to" treatment for CV19 worldwide, how is IPIX going to ramp up enough manufacturing if it is going to take months just to get enough IV to run trials?
Even worse than delaying human trials would be to succeed at human trials and then still have many thousands of people dying because B-IV is not available. The RBL had to of made known the possibility B-IV may work on many other types of viruses, its already known anti-inflammation use that could be used in many uses needing urgent care for head, lungs, kidneys, and even possibly bowels to some degree so it is not like the inventory would go to waste if it doesn't play out for CV.
I believe the peer reviewed articles are being over hyped in regards to being necessary for govt grant approval. If the data they are receiving was coming from a corporate lab, then peer review is essential. But when the data is coming from your own labs, labs that you set up for being competent and the backbone of national defense in regards to bacterial/viral threats, then that should be good enough without needing others to tell you that your own labs were competent in running their investigations.
Govt can bring in millions of doses of other extremely iffy drugs yet one that looks strong, according to their own labs, has to scratch for manufacturing sites. Major disconnect from reality there IMO.
I am in favor of IPIX running a small private human trial in Europe or Asia ASAP to get additional data to aid in setting up the USA human trial. Would also let American medicine realize their pace of play isn't cutting it.
7
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ambitious Plans Unveiled at Taiwan Weeks 2026 Forget the usual humdrum; Taiwan’s pulling no punches in its bid to become a capital powerhouse in Asia. If you'd told me years ago that Taiwan was eyeing dominance in asset management, I might've laughed. But at the 2026 Taiwan Weeks, they showed they're dead serious about it. Over 400 bigwigs and market shakers gathered,...
Continue Reading
Transfer Online Teams Up with OnchainTA Hold onto your investment hats, folks—Transfer Online is linking arms with OnchainTA to step right into the future playground of tokenized securities. Now, what's that mean? Well, it's like jumping from sailing schooners to speedboats; we're entering a whole new era in capital markets. What's At Stake? The pair-up between these...
Continue Reading
Breaking Barriers in Energy Storage Innovation Sungrow's latest swift 20-day expedition in the land of renewable energy is a bit of a jaw-dropper. They've whipped up Europe's largest operational Battery Energy Storage System (BESS) at Hams Hall, and they did it at breakneck speed. This ain't just another plug-and-play; it's the 1,243 MWh goliath that's set up to be a key...
Continue Reading
Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...
Continue Reading
Explosive Growth Ahead in Fleet Management Software If you're thinking we're about to see a seismic shift in how fleets are managed, you're spot on. The fleet management software market, worth a modest USD 1.83 billion in 2026, is projected to skyrocket to USD 6.41 billion by 2033. We’re talking a solid 19.6% CAGR here, and that’s not some small potatoes. This isn’t...
Continue Reading
Understanding the Nuts and Bolts of Storefront Glass Replacement Picture your storefront beaten and battered, glass cracks spidering over once-pristine panes. Cue Matt Sears of Bentonville Glass Inc. ready to patch things up without turning your business into a disaster zone. The homegrown hero makes his debut in HelloNation's latest chat, offering the kind of advice you...
Continue Reading
Subtle Winds of Change in Nomad Foods' Financials Ah, Nomad Foods—Europe's frozen food titan, trotting out its third quarter numbers like a well-rehearsed production line. You've got your slight revenue bump of 2.3% on reported streams, hitting €770 million. But dig a little deeper and you find organic revenue doing a waltz at 1.6% year-on-year, surprising no one...
Continue Reading
Investors Take Aim at Everest Group's Alleged Missteps Looks like Everest Group, Ltd. (NYSE: EG) has found itself knee-deep in legal quicksand. There's a class-action lawsuit afoot, spearheaded by the folks at Schall, Brown & Schwartz LLP. They're putting forward claims that Everest, a player in the securities exchange, was painting a misleading picture when it came to...
Continue Reading
Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...
Continue Reading
The Landscape Shift in DBE/ACDBE Compliance When the USDOT decided to roll out their Final Rule in September, they didn't just shuffle the deck - they reshuffled the whole game for the Disadvantaged Business Enterprise (DBE) and Airport Concession Disadvantaged Business Enterprise (ACDBE) programs. Public agencies and businesses from coast to coast have been left...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of BULGOLD’s Recent Financing BULGOLD Inc. has successfully concluded a significant non-brokered private placement. With total gross proceeds estimated at $1,076,720, this funding comes from the sale of approximately 21.5 million common shares priced at $0.05 each. This successful placement highlights the confidence investors have in BULGOLD's operational...
Continue Reading
Recognition of Quickbase's Commitment to LGBTQ+ Equality Quickbase, the innovative AI-powered work management platform, has been awarded a prestigious score of 100 in the Human Rights Campaign Foundation’s Corporate Equality Index for 2025. This index is a critical benchmarking tool that evaluates corporate policies and practices concerning LGBTQ+ workplace equality....
Continue Reading
NEHA Elevates Food Safety Through Expert Engagement As World Food Safety Day approaches, the National Environmental Health Association (NEHA) is preparing to host a compelling roundtable discussion aimed at emphasizing food safety on a global scale. This exciting virtual event, titled "Science on the Frontline: Global Voices of Food Safety Professionals," will spotlight...
Continue Reading
Seagram's Vodka Partners with the USO Seagram's Vodka, a brand celebrated for its premium American-made spirits, has proudly teamed up with the United Service Organizations (USO) by donating $100,000 to enhance support for military families. This partnership reflects not only a dedication to their product but also a commitment to the communities that Seagram's serves....
Continue Reading
Innovative Technology at Covenant Health Fort Sanders Regional Covenant Health Fort Sanders Regional is breaking new ground by becoming the first facility in its state to introduce cutting-edge technology from Perimeter Medical Imaging AI, Inc. This pioneering advancement centers around the S-Series Optical Coherence Tomography (OCT), an innovative imaging tool enhancing...
Continue Reading